CHICAGO & CAMBRIDGE, Mass.–(BUSINESS WIRE)– Exicure, Inc. (XCUR), the pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical nucleic acid (SNA™) constructs, announced today that its CFO, David Snyder, will give a company presentation on Tuesday, June 4th, 2019 at 3:40-4:00 pm MDT at the LD Micro 9th Invitational Conference.… Read More..

VANCOUVER, British Columbia, June 03, 2019 (GLOBE NEWSWIRE) — Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) will participate in multiple upcoming investment and industry conferences in June. Lift & Co. Cannabis Expo Allan Rewak, Vice President, Communications & Stakeholder Relations, will participate on a panel and be available… Read More..